Within familial pancreatic cancer, defined by the presence of two or more first-degree relatives affected with pancreatic cancer, BRCA2 mutations are discerned in about 5% to 10% of cases, and BRCA1 mutations are found in approximately 1%. This evidence concerns the gene BRCA2 and pancreatic neoplasm.